Literature DB >> 880240

Turnover of myelin proteins in mouse brain in vivo.

A Lajtha, J Toth, K Fujimoto, H C Agrawal.   

Abstract

The incorporation of tyrosine into proteins was measured after the subcutaneous implantation of a pellet of [14C]tyrosine in mice. This method keeps the specific radioactivity of free tyrosine fairly constant and makes it possible to follow incorporation up to a 10-day period. At the end of 10 days most of the protein-bound tyrosine was replaced (i.e. most protein turned over) in lung, liver, heart, kidney and spleen; about half was replaced in brain, one-quarter in muscle. The rate of protein turnover in myelin was approx. 40% of that of whole brain proteins; at 10 days one-fifth of the myelin proteins were replaced. All protein components of myelin measured were in a dynamic state; incorporation decreased in the following order, Wolfgram greater than DM-20 greater than basic greater than proteolipid proteins. The incorporation of tyrosine into each protein fraction was greater in the 0-5-day than in the 5-10-day period, indicating heterogeneity of metabolic rates. The results show that after myelination at least a portion of each protein component of myelin is undergoing significant metabolic turnover. In the adult, myelin components are not stable, but turnover is heterogeneous, and each protein may be compartmentalized. Turnover can be influenced by a variety of factors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880240      PMCID: PMC1164796          DOI: 10.1042/bj1640323

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Proteolytic digestion of bovine brain white matter proteolipid.

Authors:  M B Lees; D S Chan
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

2.  The non-synchronous synthesis of myelin components during early stages of myelination in the rat optic nerve.

Authors:  N K Detering; M A Wells
Journal:  J Neurochem       Date:  1976-02       Impact factor: 5.372

3.  Enzymic hydrolysis of myelin basic protein and other proteins in central nervous system and lymphoid tissues from normal and demyelinating rats.

Authors:  G F Buletza; M E Smith
Journal:  Biochem J       Date:  1976-06-15       Impact factor: 3.857

4.  Metabolic instability of myelin protein and proteolipid fractions.

Authors:  B D'Monte; P Mela; N Marks
Journal:  Eur J Biochem       Date:  1971-11-11

5.  The protein composition of isolated myelin.

Authors:  F Gonzalez-Sastre
Journal:  J Neurochem       Date:  1970-07       Impact factor: 5.372

6.  The turnover of myelin in the adult rat.

Authors:  M E Smith
Journal:  Biochim Biophys Acta       Date:  1968-10-22

7.  Diphtheria toxin inhibits the synthesis of myelin proteolipid and basic proteins by peripheral nerve in vitro.

Authors:  D E Pleasure; B Feldmann; D J Prockop
Journal:  J Neurochem       Date:  1973-01       Impact factor: 5.372

8.  Appearance of newly synthesized protein in myelin of young rats.

Authors:  J A Benjamins; M Jones; P Morell
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

9.  Turnover of myelin and other structural proteins in the developing rat brain.

Authors:  M I Sabri; A H Bone; A N Davison
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

10.  Lipid and basic protein interaction of myelin.

Authors:  N L Banik; A N Davison
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

View more
  16 in total

1.  Age-related molecular reorganization at the node of Ranvier.

Authors:  Jason D Hinman; Alan Peters; Howard Cabral; Douglas L Rosene; William Hollander; Matthew N Rasband; Carmela R Abraham
Journal:  J Comp Neurol       Date:  2006-04-01       Impact factor: 3.215

2.  Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.

Authors:  France Ziereisen; Bernard Dan; Nadira Azzi; Alina Ferster; Nash Damry; Catherine Christophe
Journal:  Pediatr Radiol       Date:  2005-12-21

3.  Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis.

Authors:  M J Walsh; J M Murray
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 4.  Proteins of myelin and their metabolism.

Authors:  J A Benjamins; P Morell
Journal:  Neurochem Res       Date:  1978-04       Impact factor: 3.996

5.  Developmental changes in the breakdown of brain tubulin by cerebral cathepsin D.

Authors:  M Banay-Schwartz; F Bracco; T DeGuzman; A Lajtha
Journal:  Neurochem Res       Date:  1983-01       Impact factor: 3.996

6.  Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse.

Authors:  F A Hommes; L Moss
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria.

Authors:  F A Hommes; A G Eller; E H Taylor
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

8.  Study of the expression of myelin proteolipid protein (lipophilin) using a cloned complementary DNA.

Authors:  A L Naismith; E Hoffman-Chudzik; L C Tsui; J R Riordan
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

9.  Statin therapy inhibits remyelination in the central nervous system.

Authors:  Veronique E Miron; Simone P Zehntner; Tanja Kuhlmann; Samuel K Ludwin; Trevor Owens; Timothy E Kennedy; Barry J Bedell; Jack P Antel
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 10.  Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.

Authors:  Jane M Rodgers; Andrew P Robinson; Stephen D Miller
Journal:  Discov Med       Date:  2013-08       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.